VALID Accommodations for Academic Medical Centers and Other Lab Tests

The VALID Act is carefully tailored to ensure continued access to tests offered by academic medical centers and other laboratories.
Related Reading
Blog / Government & Legislative Affairs / The MedTech Conference
AdvaMed® in Action: When Alliances Put Patients First
October 1, 2026
Behind every policy conversation is a patient waiting for access to the care and technology they need. In this edition of AdvaMed in Action, Bobby Patrick explores how collaboration among patient advocates, medtech companies, state partners and policy leaders can help advance patient access and turn shared priorities into meaningful action.
News / Diagnostics / Medical Imaging / Regulatory Affairs
Cubresa Announces FDA 510(k) Clearance for the Cubresa BrainPET™ Scanner, Opening New Frontier in Clinical Brain Imaging
August 20, 2026
WINNIPEG, MANITOBA, CANADA, August 20, 2026 /EINPresswire.com/ — Cubresa Inc., a global leader in clinical and preclinical molecular imaging technologies, today announced that it has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking Cubresa BrainPET™ scanner.
News / Diagnostics / Digital Health / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Statement on the Nomination of Dr. Heidi Overton as FDA Commissioner
August 19, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on President Trump’s nomination of Dr. Heidi Overton to serve as FDA commissioner.
News / Government & Legislative Affairs / Regulatory Affairs / Small Business
AdvaMed Names Juan Carlos “JC” Scott Chief Strategy Officer and Executive Director of AdvaMed Accel
August 12, 2026
WASHINGTON, D.C. – AdvaMed today announced that Juan Carlos “JC” Scott has been appointed Chief Strategy Officer and Executive Director of AdvaMed Accel, a newly created leadership position focused on accelerating engagement with emerging medical technology companies and strengthening AdvaMed’s role at the center of the innovation ecosystem.
Resource / Government & Legislative Affairs
Scott Whitaker Op-Ed: Medtech: A great value in American health care
August 7, 2026
In this op-ed published in The Washington Times, AdvaMed® President and CEO Scott Whitaker explains why policymakers seeking to lower health care costs should look closely at the value medtech delivers every day
Event / AdvaMed Advancements / Business Development / Government & Legislative Affairs / Regulatory Affairs / Small Business
Medtech Showcase & Reception on Capitol Hill
September 16, 2026
5:00 PM – 7:00 PM
Experience the future of health care at the 2026 Medtech Showcase and Reception on Capitol Hill. Join AdvaMed® on September 16 for an interactive event featuring more than 25 medtech companies demonstrating breakthrough technologies that are transforming patient care. See innovative medical devices firsthand, connect with industry leaders and policymakers, and discover how medtech innovation is improving and saving lives.
News / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Strongly Supports Draft MDUFA VI Agreement at FDA Public Meeting
August 5, 2026
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today expressed strong support for the draft Medical Device User Fee Amendments (MDUFA) VI agreement at an FDA public hearing.
Resource / Coverage & Payment / Government & Legislative Affairs / Health Access
Gateways to Health: How Medtech Is Improving Care While Lowering Healthcare Costs
July 31, 2026
Read Gateways to Health, a special publication exploring how medical technology improves patient care, expands access, and lowers healthcare costs.